Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Agnimantha Kwatha is a traditional Ayurvedic herbal decoction prepared from the roots or bark of *Premna integrifolia* (syn. *Premna serratifolia*) or *Clerodendrum phlomidis*. It is a cornerstone formulation in Ayurvedic medicine, primarily indicated for the management of *Sthaulya* (obesity) and various inflammatory conditions. The preparation is characterized by its *Lekhana* (scraping) property, which is traditionally believed to facilitate the reduction of excess adipose tissue and the clearance of metabolic waste products. Pharmacologically, Agnimantha Kwatha exhibits anti-inflammatory, analgesic, anti-hyperlipidemic, and antioxidant activities. These therapeutic effects are attributed to a diverse phytochemical profile that includes alkaloids, flavonoids, and glycosides such as pectolinarin and premnazole. Beyond obesity, it is frequently employed in the treatment of lymphadenitis, diabetes mellitus, and urinary tract disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on agnimantha kwatha.